| Nov 20 |
HCW Biologics prices $6.9M registered direct offering at $1.03 per share
|
| Nov 19 |
HCW Biologics announces pricing of $6.9M registered direct offering, concurrent private placement
|
| Nov 19 |
HCW Biologics Announces Pricing of $6.9 Million Registered Direct Offering and Concurrent Private Placement Priced Above Market Under NASDAQ Rules
|
| Nov 18 |
Top Midday Gainers
|
| Nov 18 |
Why Is Penny Stock HCW Biologics Surging On Monday?
|
| Nov 18 |
HCW Biologics jumps on license agreement for immunotherapeutic product candidate
|
| Nov 18 |
HCW Biologics and WY Biotech Announce License Agreement for Immunotherapeutic Product Candidate
|
| Nov 15 |
HCW Biologics reports Q3 results
|
| Nov 14 |
HCW Biologics Reports Third Quarter 2024 Financial Results and Business Highlights
|
| Aug 23 |
HCW Biologics Reports Second Quarter 2024 Financial Results and Business Highlights - Correction
|
